Parsifal Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Compass
COMP
|
+$125M |
| 2 |
Akamai
AKAM
|
+$47.7M |
| 3 |
Caesars Entertainment
CZR
|
+$46M |
| 4 |
JMIA
Jumia Technologies
JMIA
|
+$35.1M |
| 5 |
Teradata
TDC
|
+$20.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$88M |
| 2 |
Globus Medical
GMED
|
+$75M |
| 3 |
Viavi Solutions
VIAV
|
+$55.5M |
| 4 |
UnitedHealth
UNH
|
+$49.6M |
| 5 |
SharkNinja
SN
|
+$47.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 33.98% |
| 2 | Technology | 17.9% |
| 3 | Industrials | 15.62% |
| 4 | Real Estate | 10.26% |
| 5 | Materials | 6.08% |
Similar funds
Parsifal Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Parsifal Capital Management held 24 positions worth $849M, down 30% from $1.22B the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Parsifal Capital Management withdrew a net $346M in Q1 2026, closing 6 positions and reducing 11 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $88M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 34% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
Against the trend, Parsifal Capital Management opened a new position in Compass worth $87.1M.
- Parsifal Capital Management's largest Q1 2026 buy was Compass: 11,918,302 shares worth $87.1M.
- Parsifal Capital Management added most to AvePoint in Q1 2026, an estimated $665K increase.
- Parsifal Capital Management's biggest Q1 2026 reduction was Globus Medical, cutting an estimated $75M.
- Parsifal Capital Management fully exited Teva Pharmaceuticals in Q1 2026, selling an estimated $88M.
- Parsifal Capital Management's ten largest holdings make up 73% of its $849M portfolio in Q1 2026.
- Parsifal Capital Management opened 6 new positions and closed 6 in Q1 2026.
- Parsifal Capital Management's portfolio value fell 30% quarter-over-quarter to $849M.
Based on Parsifal Capital Management's 13F filing for Q1 2026, filed 15 May 2026.